Mercer Global Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,278
| Closed | -$53.4K | – | 2316 |
|
|
2024
Q3 | $53.4K | Sell |
10,278
-8,022
| -44% | -$41.7K | ﹤0.01% | 1913 |
|
|
2024
Q2 | $47K | Buy |
18,300
+32
| +0.2% | +$82 | ﹤0.01% | 1915 |
|
|
2024
Q1 | $90K | Buy |
18,268
+200
| +1% | +$985 | ﹤0.01% | 1859 |
|
|
2023
Q4 | $159K | Sell |
18,068
-35
| -0.2% | -$308 | ﹤0.01% | 1870 |
|
|
2023
Q3 | $208K | Buy |
18,103
+8,942
| +98% | +$103K | ﹤0.01% | 1746 |
|
|
2023
Q2 | $232K | Buy |
9,161
+100
| +1% | +$2.53K | ﹤0.01% | 1659 |
|
|
2023
Q1 | $292K | Sell |
9,061
-2,034
| -18% | -$65.5K | ﹤0.01% | 1530 |
|
|
2022
Q4 | $205K | Buy |
11,095
+289
| +3% | +$5.34K | ﹤0.01% | 1704 |
|
|
2022
Q3 | $292K | Buy |
10,806
+71
| +0.7% | +$1.92K | ﹤0.01% | 1428 |
|
|
2022
Q2 | $148K | Sell |
10,735
-1,996
| -16% | -$27.5K | ﹤0.01% | 1679 |
|
|
2022
Q1 | $248K | Sell |
12,731
-7,733
| -38% | -$151K | ﹤0.01% | 1611 |
|
|
2021
Q4 | $334K | Sell |
20,464
-3,087
| -13% | -$50.4K | ﹤0.01% | 1402 |
|
|
2021
Q3 | $656K | Hold |
23,551
| – | – | ﹤0.01% | 1039 |
|
|
2021
Q2 | $698K | Sell |
23,551
-4,701
| -17% | -$139K | 0.01% | 990 |
|
|
2021
Q1 | $790K | Sell |
28,252
-2,617
| -8% | -$73.2K | 0.01% | 881 |
|
|
2020
Q4 | $875K | Buy |
+30,869
| New | +$875K | 0.01% | 648 |
|